Related content

Emerging technologies from the Human Genome Project for understanding susceptibility and risk

By Spengler S.J.  

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. : 235-238

Elsevier

Access to resources Recommend Favorite

Human Papilloma Virus: The Most Common Sexually Transmitted Disease

By  

Pharmaceutical Innovation, Vol. 11, Iss. 1, 2001-12 ,pp. : 18-21

Adis International

Access to resources Recommend Favorite

Genetic Variation of Human UDP-Glucuronosyltransferase: Implications in Disease and Drug Glucuronidation

By Burchell B.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 1, 2003-01 ,pp. : 37-52

Adis International

Access to resources Recommend Favorite

Human Genome Sciences: patenting the genome

By Thomas S.M.   Burke J.F.  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 11, 1997-11 ,pp. : 1257-1264

Informa Healthcare

Access to resources Recommend Favorite

Human Cancer Risk Estimates Are Reduced When Based on Relative Risk for Common Rodent Tumors

By Gaylor D.W.   Kodell R.L.   Chen J.J.  

Regulatory Toxicology and Pharmacology, Vol. 30, Iss. 3, 1999-12 ,pp. : 283-284

Academic Press

Access to resources Recommend Favorite